Is STERIS plc (STE) undervalued? · P/E 25, rev $5.46B
STERIS plc (STE) is a medical devices company listed on NYSE.
This page asks whether STERIS plc (STE) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
STE currently screens at market cap $19.43B and trailing P/E 25.1. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new STE 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare STE to the stock page model before you treat a low multiple as a gift.
Not investment advice.